Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Complications associated with carrier status among people with blood disorders: a commentary.

Hooper WC, Miller CH, Key NS.

Am J Prev Med. 2010 Apr;38(4 Suppl):S456-8. doi: 10.1016/j.amepre.2010.01.009. No abstract available.

PMID:
20331943
2.

Genetic testing. New high-tech screen takes carrier testing to the next level.

Couzin-Frankel J.

Science. 2011 Jan 14;331(6014):130-1. doi: 10.1126/science.331.6014.130. No abstract available. Erratum in: Science. 2011 Apr 1;332(6025):36.

PMID:
21233351
3.

Carrier screening for cystic fibrosis: a perinatal perspective.

Demsey SA.

J Perinat Neonatal Nurs. 1999 Sep;13(2):14-26. Review.

PMID:
10818851
4.

Carrier detection and prenatal screening of the retinoblastoma gene.

Cowell JK, Onadim Z.

J Pathol. 1990 May;161(1):3-5. Review. No abstract available.

PMID:
2196349
5.

Outcomes of a cystic fibrosis carrier testing clinic for couples.

O'Leary PC, Maxwell SJ, Youngs LM, Brameld KJ, Walpole IR.

Med J Aust. 2010 Feb 15;192(4):238; author reply 238-9. No abstract available.

PMID:
20170468
6.

Approaches to prenatal cystic fibrosis carrier screening.

Brock D.

J Med Genet. 1993 Jul;30(7):621. No abstract available.

7.

Carrier detection of phenylketonuria in Iranian families by variable number tandem-repeat polymorphism analysis.

Hosseini-Mazinani SM, Koochmeshgi J, Khazaee-Koohpar Z, Hosein-Pur-Nobari N, Seifati SM.

East Mediterr Health J. 2008 Nov-Dec;14(6):1445-51.

PMID:
19161120
8.

A 10-year large-scale cystic fibrosis carrier screening in the Italian population.

Picci L, Cameran M, Marangon O, Marzenta D, Ferrari S, Frigo AC, Scarpa M.

J Cyst Fibros. 2010 Jan;9(1):29-35. doi: 10.1016/j.jcf.2009.10.003. Epub 2009 Nov 7.

9.
10.
11.

Variable clinical phenotypes of alpha-thalassemia syndromes.

Singer ST.

ScientificWorldJournal. 2009 Jul 13;9:615-25. doi: 10.1100/tsw.2009.69. Review.

12.

A new approach to prenatal cystic fibrosis carrier screening.

Miedzybrodzka Z, Haites N, Dean J.

J Med Genet. 1993 Jan;30(1):86. No abstract available.

13.

Genetic testing from different angles. Introduction.

Lucassen A, Clancy T.

Fam Cancer. 2010 Mar;9(1):1. doi: 10.1007/s10689-010-9322-0. No abstract available.

PMID:
20099038
14.

Women's attitudes toward testing for fragile X carrier status: a qualitative analysis.

Anido A, Carlson LM, Taft L, Sherman SL.

J Genet Couns. 2005 Aug;14(4):295-306.

PMID:
16047092
15.

Prevalence of inherited bleeding disorders in cases of idiopathic menorrhagia: a case of five blind men describing an elephant.

Ghosh K, Trasi S, Nair S, Shetty S, Mohanty D.

J Thromb Haemost. 2003 Oct;1(10):2242-3. No abstract available.

16.

It's "back to school" for genetic screening.

Gason AA, Delatycki MB, Metcalfe SA, Aitken M.

Eur J Hum Genet. 2006 Apr;14(4):384-9. Review.

17.

Carrier screening and prenatal diagnosis of beta-thalassemia.

Maheshwari M, Arora S, Kabra M, Menon PS.

Indian Pediatr. 1999 Nov;36(11):1119-25. Review. No abstract available.

PMID:
10745333
18.

Lessons (re)learned from cystic fibrosis carrier screening.

Clayton EW.

J Gend Specif Med. 1999 Nov-Dec;2(6):21-4. No abstract available.

PMID:
11279867
19.

Is cascade testing a sensible method of screening a population for autosomal recessive disorders?

Morris JK, Law MR, Wald NJ.

Am J Med Genet A. 2004 Jul 30;128A(3):271-5.

PMID:
15216548
20.

Screening for alpha-thalassemia in neonates. Routine erythrocyte measurements.

Hall FW, Lundgrin DB.

Am J Clin Pathol. 1987 Mar;87(3):389-91.

Items per page

Supplemental Content

Write to the Help Desk